Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants

Intravenous remdesivir (RDV) is US Food and Drug Administration–approved for hospitalized and nonhospitalized individuals with coronavirus disease 2019. RDV undergoes intracellular metabolic activation to form the active triphosphate, GS‐443902, and other metabolites. Alternative administration rout...

Descripción completa

Detalles Bibliográficos
Autores principales: Humeniuk, Rita, Juneja, Kavita, Chen, Shuguang, Ellis, Scott, Anoshchenko, Olena, Xiao, Deqing, Share, Aaron, Johnston, Matthew, Davies, Santosh, DeZure, Adam, Llewellyn, Joe, Osinusi, Anu, Winter, Helen, Girish, Sandhya, Palaparthy, Ramesh, Dresser, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651641/
https://www.ncbi.nlm.nih.gov/pubmed/37688349
http://dx.doi.org/10.1111/cts.13627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651641/
https://www.ncbi.nlm.nih.gov/pubmed/37688349
http://dx.doi.org/10.1111/cts.13627

Ejemplares similares